Medindia

X

PCMA Statement on New IMS Health Drug Spending Report

Thursday, April 14, 2016 Drug News J E 4
Advertisement

WASHINGTON, April 14, 2016 /PRNewswire-USNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on a new report from the IMS Institute for Healthcare Informatics, Medicines Use and Spending in the U.S.: A Review of 2015 and Outlook to 2020:

"This report highlights how tools used by pharmacy benefit managers restrain costs for commercial and government payers by increasing competition among drugmakers. This competitive model should be used to root out wasteful spending in unmanaged programs where PBM tools are not widely employed."

PCMA is the national association representing America's pharmacy benefit managers (PBMs).  PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including:  commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

Follow PCMA on Twitter

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pcma-statement-on-new-ims-health-drug-spending-report-300251718.html

SOURCE Pharmaceutical Care Management Association

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
A new experience in hot yoga - Modo Yoga Portland ...
S
Senior Home Care of Spokane Now Open